NCT06478108View on ClinicalTrials.gov

Interventional Software for Multi-immunotherapy of Solid Tumors

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 30, 2028

Study Completion Date

December 30, 2033

Conditions
Lung CancerLiver CancerSolid Tumor, Adult
Interventions
DEVICE

IRSW-MIM

IRSW-MIM collects patient's data and outputs a therapeutical strategy for treating advanced solid tumors.

Trial Locations (1)

Unknown

RECRUITING

Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
collaborator

Immuno (Guangzhou) Biomedicine S&T Ltd

UNKNOWN

lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER

NCT06478108 - Interventional Software for Multi-immunotherapy of Solid Tumors | Biotech Hunter | Biotech Hunter